Biote Corp Ownership
| BTMD Stock | USD 5.98 0.16 2.61% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Biote |
Biote Stock Ownership Analysis
About 27.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. biote Corp. operates in medical practice-building business within the hormone optimization space. The company was founded in 2011 and is headquartered in Irvine, Texas. Biote Corp operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. For more info on biote Corp please contact Teresa Weber at 844 604 1246 or go to https://biote.com.Besides selling stocks to institutional investors, Biote Corp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Biote Corp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Biote Corp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Biote Corp Quarterly Liabilities And Stockholders Equity |
|
About 27.0% of biote Corp are currently held by insiders. Unlike Biote Corp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Biote Corp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Biote Corp's insider trades
Biote Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Biote Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading biote Corp backward and forwards among themselves. Biote Corp's institutional investor refers to the entity that pools money to purchase Biote Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 272.4 K | Northern Trust Corp | 2024-09-30 | 262.5 K | Skylands Capital, Llc | 2024-09-30 | 198.5 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 197.9 K | Smh Capital Inc. | 2024-09-30 | 181 K | Renaissance Technologies Corp | 2024-09-30 | 163 K | Millennium Management Llc | 2024-06-30 | 119.6 K | Bank Of New York Mellon Corp | 2024-06-30 | 94.3 K | Goldman Sachs Group Inc | 2024-06-30 | 93.7 K | 325 Capital Llc | 2024-09-30 | 4.5 M | Bandera Partners Llc | 2024-09-30 | 2.4 M |
biote Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biote Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biote Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Biote Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Biote Corp Outstanding Bonds
Biote Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. biote Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biote bonds can be classified according to their maturity, which is the date when biote Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| BIOGEN INC 52 Corp BondUS09062XAD57 | View | |
| BIOGEN INC 405 Corp BondUS09062XAF06 | View | |
| BIOGEN INC Corp BondUS09062XAG88 | View | |
| BIOGEN INC Corp BondUS09062XAH61 | View | |
| BIIB 325 15 FEB 51 Corp BondUS09062XAK90 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Biote Corp Corporate Filings
| 13th of November 2024 Other Reports | ViewVerify | |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 22nd of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 11th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether biote Corp is a strong investment it is important to analyze Biote Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biote Corp's future performance. For an informed investment choice regarding Biote Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in biote Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biote Corp. If investors know Biote will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biote Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.375 | Earnings Share 0.3 | Revenue Per Share 5.767 | Quarterly Revenue Growth 0.128 | Return On Assets 0.1816 |
The market value of biote Corp is measured differently than its book value, which is the value of Biote that is recorded on the company's balance sheet. Investors also form their own opinion of Biote Corp's value that differs from its market value or its book value, called intrinsic value, which is Biote Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biote Corp's market value can be influenced by many factors that don't directly affect Biote Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biote Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biote Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.